scispace - formally typeset
H

Henri Christian Junior Tsoungui Obama

Researcher at African Institute for Mathematical Sciences

Publications -  4
Citations -  39

Henri Christian Junior Tsoungui Obama is an academic researcher from African Institute for Mathematical Sciences. The author has contributed to research in topics: Population & Vaccination. The author has an hindex of 2, co-authored 4 publications receiving 10 citations. Previous affiliations of Henri Christian Junior Tsoungui Obama include Hochschule Mittweida.

Papers
More filters
Journal ArticleDOI

Preventing COVID-19 spread in closed facilities by regular testing of employees-An efficient intervention in long-term care facilities and prisons?

TL;DR: In this article, the simulation model underlying the pandemic preparedness tool CovidSim 1.1 (http://covidsim.eu/) is extended to investigate the effect of regularly testing of employees to protect immobile resident risk groups in closed facilities.
Journal ArticleDOI

The impact of COVID-19 vaccination campaigns accounting for antibody-dependent enhancement.

TL;DR: In this article, the authors introduce a complex extension of the model underlying the pandemic preparedness tool CovidSim 1.1 (http://covidsim.eu/) to optimize vaccination strategies with regard to the onset of campaigns, vaccination coverage, vaccination schedules, vaccination rates, and efficiency of vaccines.
Posted ContentDOI

The impact of COVID-19 vaccination campaigns accounting for antibody-dependent enhancement

TL;DR: In this article, a complex extension of the model underlying the pandemic preparedness tool CovidSim 1.1 (http://covidsim.eu/) is introduced to optimize vaccination strategies with regard to the onset of campaigns, vaccination coverage, vaccination schedules, vaccination rates, and efficiency of vaccines.
Journal ArticleDOI

Is increased mortality by multiple exposures to COVID-19 an overseen factor when aiming for herd immunity?

Abstract: Background Governments across the globe responded with different strategies to the COVID-19 pandemic. While some countries adopted measures, which have been perceived controversial, others pursued a strategy aiming for herd immunity. The latter is even more controversial and has been called unethical by the WHO Director-General. Inevitably, without proper control measures, viral diversity increases and multiple infectious exposures become common, when the pandemic reaches its maximum. This harbors not only a potential threat overseen by simplified theoretical arguments in support of herd immunity, but also deserves attention when assessing response measures to increasing numbers of infection. Methods and findings We extend the simulation model underlying the pandemic preparedness web interface CovidSim 1.1 (http://covidsim.eu/) to study the hypothetical effect of increased morbidity and mortality due to 'multi-infections', either acquired at by successive infective contacts during the course of one infection or by a single infective contact with a multi-infected individual. The simulations are adjusted to reflect roughly the situation in the USA. We assume a phase of general contact reduction ("lockdown") at the beginning of the epidemic and additional case-isolation measures. We study the hypothetical effects of varying enhancements in morbidity and mortality, different likelihoods of multi-infected individuals to spread multi-infections and different susceptibility to multi-infections in different disease phases. It is demonstrated that multi-infections lead to a slight reduction in the number of infections, as these are more likely to get isolated due to their higher morbidity. However, the latter substantially increases the number of deaths. Furthermore, simulations indicate that a potential second lockdown can substantially decrease the epidemic peak, the number of multi-infections and deaths. Conclusions Enhanced morbidity and mortality due to multiple disease exposure is a potential threat in the COVID-19 pandemic that deserves more attention. Particularly it underlines another facet questioning disease management strategies aiming for herd immunity.